Literature DB >> 21394047

Comparison of PET-CT images with the histopathological picture of a resectable primary tumor for delineating GTV in nonsmall cell lung cancer.

Shan Lin1, Bo Han, Lijuan Yu, Dan Shan, Ruizhi Wang, Xiaoming Ning.   

Abstract

OBJECTIVE: This study was designed to investigate the feasibility of a method derived from fused positron emission tomography-computed tomography (PET-CT) images for the delineation of gross tumor volume (GTV) in nonsmall cell lung cancer (NSCLC) and to explore the correlation between PET-CT and histopathological findings.
METHODS: Thirty-seven patients were enrolled in this study; all patients were evaluated by PET-CT and underwent surgery within 1 week after the scan. The radiation oncologist, together with the radiologist, first delineated the GTV-based CT and then with an experienced nuclear medicine physician contoured the same GTV using the distinctive visual 'halo' in fused PET-CT images. The characteristics of the halo phenomenon were analyzed, including the standardized uptake value (SUV). The excised surgical specimens were labeled and the maximum diameter of the tumor in the right-left axis of the tissue blocks was measured on consecutive histopathology slides; the histopathological slice images were scanned using a digital pathology scanner after staining with hematoxylin and eosin.
RESULTS: The mean SUV of the external margins of the halos was 2.41±0.73 (range 1.4-4.1); the histopathological type and T-stage significantly influenced the SUV of the external margin of the halos (P=0.004 and 0.027). The correlation coefficients of maximum diameter in the right-left axis and in the anterior-posterior axis between fused PET-CT images and histopathology were 0.935 and 0.943, respectively; the values between CT imaging and histopathological examination were 0.82 and 0.763.
CONCLUSION: There is a correlation between GTV based on the'halo' of fused PET-CT images and the excised surgical specimen of primary tumor.It may be feasible to use the 'halo' characteristics in fused PET-CT images to delineate GTV in NSCLCs, but its reliability should be further investigated to establish an accurate spatial imaging-pathology correlation for primary tumors delineation in NSCLCs.

Entities:  

Mesh:

Year:  2011        PMID: 21394047     DOI: 10.1097/MNM.0b013e32834508d2

Source DB:  PubMed          Journal:  Nucl Med Commun        ISSN: 0143-3636            Impact factor:   1.690


  4 in total

1.  Overcoming the hurdles of using PET/CT for target volume delineation in curative intent radiotherapy of non-small cell lung cancer.

Authors:  Leila Tchelebi; Hani Ashamalla
Journal:  Ann Transl Med       Date:  2015-08

2.  Use of FDG-PET in Radiation Treatment Planning for Thoracic Cancers.

Authors:  Katsuyuki Shirai; Akiko Nakagawa; Takanori Abe; Masahiro Kawahara; Jun-Ichi Saitoh; Tatsuya Ohno; Takashi Nakano
Journal:  Int J Mol Imaging       Date:  2012-05-14

Review 3.  The utility of positron emission tomography in the treatment planning of image-guided radiotherapy for non-small cell lung cancer.

Authors:  Alexander Chi; Nam P Nguyen
Journal:  Front Oncol       Date:  2014-10-07       Impact factor: 6.244

4.  Use of Positron Emission Tomography/Computed Tomography in Radiation Treatment Planning for Lung Cancer.

Authors:  Kezban Berberoğlu
Journal:  Mol Imaging Radionucl Ther       Date:  2016-06-05
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.